Previously, the reading of the Income Tax Act led to proceeds from exits to be considered business income for domestic ...

HistoSonics Inc., a medical device company whose backers include Johnson & Johnson's venture capital arm, is considering a ...

Mike’s got more than 30 years’ experience in financial services,” says Pickerell. “He’s entrepreneurial and has good connections with clients. He’s been on our radar screen for some time.” Hong ...

Türkiye's startup ecosystem ended 2024 with 469 investment deals, totaling $1.1 billion (TL 39.23 billion), according to industry monitor data.

Shares of Infinity Natural Resources jumped almost 11% in their NYSE debut, valuing the oil and natural gas producer at $1.3B. The listing ...

Shares of weight-loss drug developer Metsera surged nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture Partners-backed biotech firm at $2.68 billion. Shares of the company opened ...

The Company has added an Australian entity, Max Brazil, to hold the "Florália DSO Project" through the existing Canadian and Brazilian holding entities. As announced on January 9, 2025, Max Brazil ...

Metsera, along with Maze Therapeutics, gave U.S. health care first-time share sales its best month since October.

Private equity will have a more positive 2025 than it's had recent years, and institutional investors will likely turn their ...

Sources privy to the development said that the company is actively streamlining its operations to address various challenges ...

The UK biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.

The company launched the IPO after doubling revenue in 2024, driven by increased oil production from well acquisitions worth ...